SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form C - Offering Statement:
SEC Accession No. 0001104659-23-112915
Filing Date
2023-10-31
Accepted
2023-10-31 15:49:06
Documents
4

Document Format Files

Seq Description Document Type Size
1 primary_doc.html C  
1 primary_doc.xml C 10470
2 EXHIBIT 99.A tm2329430-1_ex99a.pdf EX-99 2130309
3 EXHIBIT 99.B tm2329430-1_ex99b.pdf EX-99 38637
4 EXHIBIT 99.C tm2329430-1_ex99c.pdf EX-99 6587477
  Complete submission text file 0001104659-23-112915.txt   9940369
Mailing Address 3811 TURTLE CREEK BLVD., STE 875 DALLAS TX 75219
Business Address 3811 TURTLE CREEK BLVD., STE 875 DALLAS TX 75219 214-651-4000
LexaGene Life Sciences CF Investors, Inc. (Filer) CIK: 0001998226 (see all company filings)

IRS No.: 933011996 | State of Incorp.: DE | Fiscal Year End: 1231
Type: C | Act: 33 | File No.: 020-33135 | Film No.: 231364417